Chemed Corporation (CHE) Misses Q2 EPS by $1.12, Misses on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $504.06 -0.38%
EPS Growth %: +23.0%
Financial Fact:
Income from operations: 42.87M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: +23.0%
Financial Fact:
Income from operations: 42.87M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Chemed Corporation (NYSE: CHE) reported Q2 EPS of $4.27, $1.12 worse than the analyst estimate of $5.39. Revenue for the quarter came in at $618.8 million versus the consensus estimate of $650.6 million.
GUIDANCE:
Chemed Corporation sees FY2025 EPS of $22.00-$22.30, versus the consensus of $23.29.
For earnings history and earnings-related data on Chemed Corporation (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
